Development decisions are increasingly made early, based on strategic hypotheses (positioning, differentiation, claims, access pathway), while the competitive landscape and payer/authority expectations keep evolving.
Teams must translate strategic documents (TPP, clinical strategy, launch plan) into concrete evidence needs, then verify whether existing evidence packs already cover those needs - or whether gaps could block future time-to-market.
Without a structured approach, evidence planning becomes reactive, fragmented, and difficult to prioritize.
3× faster gap identification
Accelerate evidence gap identification by automating the mapping from strategy + competition -> evidence packs, and generating a structured gap analysis.
30% less rework
Reduce late-stage iterations by aligning evidence needs early with observed expectations (competition, markets, HTA) and the true state of your evidence.
Prioritized evidence roadmap
Get a clear, defensible plan of the next evidence to produce (what, why, for which market), with shareable rationale and traceability.
How it works
1
Ingest product strategy — import key documents (TPP, clinical strategy, access/HEOR strategy, claims, target markets) and structure objectives and hypotheses to be validated.
2
Cross with competitive intelligence — retrieve and summarize competitor signals (approvals, labels, HTA decisions, endpoints, comparators, RWE/HEOR patterns) to calibrate the expected level of evidence.
3
Compare against existing evidence packs — map each need (claim/endpoint/population/comparator/market) to evidence already available in your packs to identify gaps, redundancies, and risks.
4
Prioritize and plan future evidence — generate an evidence roadmap (studies, RWE, SLR, HEOR analyses, publications) with prioritization, justification, and traceability back to strategy and competition.
Strategy-to-evidence mapping: turns strategic documents into actionable, verifiable evidence requirements.
Evidence-pack confrontation + traceability: identifies gaps with direct links to sources (strategy, competition, evidence packs) and a run record for review/audit.